Next Generation Sequencing (NGS) device with post-warranty service agreement options

The Food and Drug Administration’s National Center for Toxicological Research is seeking a next generation sequencing device to support its Microbiology Surveillance Program, aiming to identify and quantify potential pathogens across a broad range of samples including lab animals, biological materials, feeds, water, bedding, and environmental sources. The equipment must enable precise, high-throughput genomic analysis to ensure the safety and integrity of research environments and associated materials. The requirement includes options for post-warranty service agreements to ensure long-term operational reliability, technical support, and maintenance beyond the initial warranty period. The solicitation is classified under NAICS code 334516, indicating a focus on laboratory machinery and equipment manufacturing, and is posted as a forecast with no set-aside designation. All communications and inquiries should be directed to Nick Sartain, who serves as both the Program Point of Contact and the Contracting Officer, with contact information provided via email. The device is intended for use at the NCTR facility, though specific location details are not listed. The opportunity is accessible through the HHS OSDBU portal for interested vendors to prepare responses ahead of a formal solicitation.